Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients

Clinical trial NCT07303296 · RECRUITING

Trial details

NCT number: NCT07303296
Sponsor: GenSight Biologics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Leber Hereditary Optic Disease

Start date: 2026-01-22
Primary completion: 2028-05-15
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.